Skip to main content

Table 1 IC50 values (μM) of erlotinib treatment in three HNSCC cell lines (mean ± standard deviation)

From: The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

Cell line Normoxia 24 h hypoxia 72 h hypoxia
LICR-HN2 2.26 ± 0.83 1.06 ± 1.42 3.34 ± 1.25
LICR-HN5 1.16 ± 0.35 0.60 ± 0.23 1.49 ± 0.60
SC263 1.05 ± 0.12 0.95 ± 0.16 0.81 ± 0.12